Corrigendum to "Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany"
Breast. 2021 Feb:55:138-139.
doi: 10.1016/j.breast.2020.12.007.
Epub 2021 Jan 5.
1 National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany.
2 Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
3 Charité University Hospital, Berlin, Campus Benjamin Franklin, Department of Hematology, Oncolo0gy and Tumour Immunology, Berlin, Germany.
4 Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany.
5 ClinSol GmbH & Co KG, Würzburg, Germany.
6 Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany. Electronic address: peter.fasching@uk-erlangen.de.
7 Department of Gynecology and Obstetrics, Düsseldorf University Hospital, Germany.
8 Gynäkologische Praxisklinik am Rosengarten, Mannheim, Germany.
9 Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg, Germany; Biostatistics Unit, Erlangen University Hospital, Department of Gynecology and Obstetrics, Erlangen, Germany.
10 Frankfurt Center of Bone Health Frankfurt, Germany.
11 Department of Obstetrics and Gynecology, University of Tuebingen, Tuebingen, Germany.
13 Department of Gynecology and Obstetrics, Ulm University Hospital, Ulm, Germany.
14 Marienhospital Bottrop, Bottrop, Germany.
15 Gynecology I (Gynecologic Oncology), Gynäkologisches Zentrum Bonn Friedensplatz, Bonn, Germany.
16 Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
17 Oncologianova GmbH, Recklinghausen, Germany.
18 Oncology Practice at Bethanien Hospital, Frankfurt, Germany.
19 National Center for Tumor Diseases, Heidelberg University Hospital, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
20 Department of Gynecology, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany.
21 Department of Gynecology and Obstetrics, Helios Clinics Berlin Buch, Berlin, Germany.
22 National Center for Tumor Diseases and Department of Gynecology and Obstetrics, Dresden University Hospital, Dresden, Germany.
23 Department of Gynecology and Obstetrics, Breast Center, and CCC Munich, Munich University Hospital, Germany.
24 Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.